A Comparison of Exhaled Carbon Monoxide Measurements Using the iCOquit Smokerlyzer and Vitalograph Breath CO Monitor vs Carboxyhemoglobin From Venous Samples While Validating a Mobile Research Application (COCO)

R

Rose Research Center

Status

Completed

Conditions

Smoking, Cigarette

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT04826549
COCO

Details and patient eligibility

About

The main objective of this study is to determine the accuracy and precision of the iCOquit Smokerlyzer as compared with the gold standard of COHb levels measured in venous plasma samples, as well as assessing its agreement with the Vitalograph BreathCO monitor. Validating the precision and accuracy of the iCOquit Smokerlyzer could establish an additional, less expensive, reliable method for determining smoking status in tobacco research. Additionally, the portability of the device would allow for remote biochemical verification of smoking status, thus enlarging the number of participants that can be included in intervention studies.

Enrollment

30 patients

Sex

All

Ages

21 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Has signed the ICF and is able to read and understand the information provided in the ICF.
  • Is 21 to 65 years of age (inclusive) at screening.
  • No intention of quitting smoking in the next 30 days.
  • Willing and able to comply with the requirements of the study.
  • Owns a smartphone running iOS or Android with text message and data capabilities compatible with the eResearch app.

Exclusion criteria

  • Is unhealthy or cannot participate in the study for any reason (e.g., medical, psychiatric, and/or social reason) as judged by the Investigators or designated medical staff based on all available assessments from the screening period (e.g., vital signs, physical examination, concomitant medications and medical history).
  • PHQ-9 score greater than 9, or a score greater than 0 on item #9 ("Thoughts you would be better off dead, or of hurting yourself in some way") at screening.
  • Body mass index (BMI) greater than 40.0 kg/m2

Use of any of these products in the past 30 days:

  • Illegal drugs (or if the urine drug screen is positive for cocaine, THC, amphetamines, methamphetamines, or opiates),
  • Experimental (investigational) drugs that are unknown to participant,
  • Chronic opioid use.
  • Pregnant or nursing (by self-report) or positive urine pregnancy test.

Participant enrollment numbers met.

-

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems